Horizon Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Sell |
807
-362
| -31% | -$54.9K | ﹤0.01% | 925 |
|
|
2025
Q1 | $176K | Buy |
1,169
+38
| +3% | +$5.72K | 0.01% | 562 |
|
|
2024
Q4 | $209K | Sell |
1,131
-123
| -10% | -$22.7K | 0.01% | 531 |
|
|
2024
Q3 | $247K | Sell |
1,254
-85
| -6% | -$16.7K | 0.01% | 504 |
|
|
2024
Q2 | $277K | Buy |
1,339
+79
| +6% | +$16.3K | 0.01% | 467 |
|
|
2024
Q1 | $341K | Buy |
1,260
+23
| +2% | +$6.23K | 0.01% | 423 |
|
|
2023
Q4 | $292K | Buy |
1,237
+52
| +4% | +$12.3K | 0.01% | 430 |
|
|
2023
Q3 | $232K | Buy |
1,185
+48
| +4% | +$9.41K | 0.01% | 473 |
|
|
2023
Q2 | $239K | Buy |
1,137
+176
| +18% | +$37K | 0.01% | 474 |
|
|
2023
Q1 | $194K | Buy |
961
+8
| +0.8% | +$1.62K | 0.01% | 522 |
|
|
2022
Q4 | $208K | Buy |
+953
| New | +$208K | 0.01% | 520 |
|